Natural Capsules logo

Natural Capsules financials: balance sheet, profit and loss, cash flow

NSE: NATCAPSUQBSE: 524654Pharmaceuticals & BiotechnologySmall Cap

Natural Capsules Limited · Face value ₹10 · Listed Oct 1994 on BSE, Feb 2025 on NSE
Last close ₹138.06up ₹0.13 (0.09%)BSE ₹136.00

Share price at the NSE close on 30 Oct 2026. Previous close ₹137.93.

30 Oct: open ₹138.00, high ₹140.97, low ₹134.05

52-week range of traded prices to 30 Oct 2026
₹132.02Low, 29 Oct 2026₹234.00High, 4 Sep 2026
Market cap
₹144 Cr2,533rd largest listed
P/E
Lossover the last 12 months
P/B
0.65
Dividend yield
Nonein the last 12 months
ROE
−9.5%
ROCE
−5.2%
Debt to equity
0.49
Volume, NSE
3,169

Natural Capsules' financial statements for the 10 years to Mar 2026, standalone: the listed company alone, without its subsidiaries, with the twelve months to Jun 2026 after them.

10 years at a glance

₹ crore, years to March.Natural Capsules annual reports

Revenue, net profit and borrowings, ₹ crore

  • Revenue
  • Net profit
  • Borrowings
540.6Mar 17551.1Mar 18601.9Mar 19620.8Mar 20807.09.6Mar 211351431Mar 221731949Mar 231547.862Mar 241686.755Mar 251741158Mar 26

Operating and net margin, per cent

  • Operating margin
  • Net margin
20.5%1.2%9.3%9.9%7.9%8.6%13.8%18.9%20.5%13.5%11.5%12.3%1.2%2.0%3.2%1.4%8.7%10.3%11.1%5.1%4.0%6.5%Mar 17Mar 19Mar 21Mar 23Mar 25Mar 26

From Apr 2019 leases sit on the balance sheet: rent is charged as depreciation and interest instead, so operating profit and total assets step up with nothing about the business having changed. Borrowings here leave lease liabilities out. Lease payments were 0.9% of operating profit in the first full year.

The years either side of a change of basis do not compare. From the year to Mar 2018, the company's revenue for that year, ₹55 Cr, differs from its quarters added, ₹58 Cr.

Results for the year to Mar 2026

Standalone: the listed company alone, without its subsidiaries. ₹ crore.

From revenue to net profit

  1. Revenue174
  2. Materials and goods−87
  3. Employee costs−15
  4. Other expenses−50
  5. Operating profit21
  6. Depreciation−8.2
  7. Other income+7.7
  8. One-off items0.0
  9. Finance costs−5.8
  10. Profit before tax15
  11. Tax−3.9
  12. Net profit11

What the company owns

  • Plant, investments and other assets₹212 Cr
  • Receivables₹61 Cr
  • Inventory₹20 Cr
  • Cash and bank₹2 Cr

What pays for it: net worth and liabilities

  • Net worth₹180 Cr
  • Borrowings₹58 Cr
  • Owed to suppliers₹42 Cr
  • Other liabilities₹16 Cr

Profit and loss

Standalone, ₹ crore, years to March. The last column is the twelve months to Jun 2026, the latest four quarters added.Natural Capsules quarterly results

₹ croreMar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026Jun 2026Twelve months
Revenue from operations5455606280135173154168174173
4949555669110137133149152149
Materials and goods bought2424232837607977848785
Employee costs6––78101112141515
Other expenses18––2123404844515050
Operating profit before depreciation555511263521192123
Operating margin9.3%9.9%7.9%8.6%13.8%18.9%20.5%13.5%11.5%12.3%13.4%
Materials, % of revenue45.2%––45.5%47.1%44.3%45.7%50.2%50.0%50.2%49.2%
Employee costs, % of revenue11.1%––11.4%10.1%7.1%6.2%8.0%8.2%8.8%8.7%
Other expenses, % of revenue34.4%––34.5%29.0%29.7%27.6%28.3%30.3%28.7%28.7%
Depreciation and amortisation44344579888
Operating profit after depreciation11217202812111315
Other income11111113488
Finance costs10010245666
Profit before one-off items and tax1221719261091517
One-off items−1–0–2000000
Profit before tax0221919261091517
01012573345
Net profit112171419871113
Other comprehensive income––––0000000
Total comprehensive income––––71419861113
Net margin1.2%2.0%3.2%1.4%8.7%10.3%11.1%5.1%4.0%6.5%7.4%
Materials, employee costs and other expenses are shown for the years they add up to operating expenses; for the years to Mar 2018 and Mar 2019 they do not, so they are left blank.

Balance sheet

Standalone, ₹ crore, at 31 March.

₹ croreMar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
6283124132166180
Share capital67991010
Reserves5676115123156169
103149625558
334560707591
11526302626
Total assets97143210231268296
57107136140171205
393775919791
Net debt92847535256
Borrowings are counted again inside the liabilities due within a year and after a year. No balance sheet is on record for the years to Mar 2017, Mar 2018, Mar 2019 and Mar 2020, so its lines and the ratios worked from it are blank there.

Cash flow

Standalone, ₹ crore, years to March.

₹ croreMar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
5.35.138.45.418.036.2
7.711.743.97.420.147.0
−4.3−15.98.3−15.00.415.3
Receivables3.10.2−26.0−1.7−7.81.1
Inventories−1.32.0−3.8−9.2−3.60.8
Payables9.11.69.82.26.14.8
Other working capital−15.2−19.828.2−6.35.78.5
Tax paid−2.2−4.7−5.5−2.0−2.1−3.6
Interest paid−0.2−2.00.00.00.00.0
Capital spending16.428.837.28.02.39.7
Free cash flow−11.1−23.71.2−2.615.726.5
−8.5−30.4−75.4−10.8−34.4−33.8
3.026.536.17.214.8−2.8
Dividends paid0.40.00.80.90.00.0
Shares bought back0.00.00.00.00.00.0
Shares issued0.07.822.60.627.80.0
Net change in cash−0.21.2−0.91.8−1.5−0.5
Capital spending is part of cash from investing, and dividends paid, shares bought back and shares issued are part of cash from financing. Each is shown as an amount on a line of its own, and the section's other items are in its total only. No cash flow statement is on record for the years to Mar 2017, Mar 2018, Mar 2019 and Mar 2020.

Per share

Standalone, ₹ per share, years to March.

₹ per shareMar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Earnings per share₹0.10₹1.78₹3.08₹1.41₹11.04₹19.62–₹8.64₹6.12₹10.79
Diluted earnings per share–₹1.78₹3.08₹1.41₹11.04₹19.62–₹8.64₹6.12₹10.79
Book value per share––––₹99.73₹118.48₹132.69₹141.33₹160.83₹173.03
Shareholder yield––––0.6%−1.8%−6.0%0.1%−14.6%0.0%
Market cap at the year end (₹ crore)4965412067432367286191149
Earnings per share is left blank for the year to Mar 2023: the earnings per share is stated as 0 while the period's profit or loss comes to at least half a paisa a share, so the 0 stands in for a figure the filing does not give.

Ratios

Standalone, years to March.Natural Capsules PE ratio and valuation

RatioMar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Revenue growth––9.2%3.0%29.2%69.9%28.0%−11.0%9.2%3.5%
Operating profit growth––−12.8%12.3%106.8%132.7%38.9%−41.4%−7.1%10.5%
Net profit growth–76.9%74.6%−56.7%727.4%100.9%37.5%−59.4%−14.0%67.1%
Earnings per share growth–1,680.0%73.0%−54.2%683.0%77.7%––−29.2%76.3%
––––11.2%19.2%18.5%6.1%4.5%6.5%
–––––8.0 pts−0.7 pts−12.4 pts−1.6 pts2.0 pts
From the net margin–––––2.0 pts1.4 pts−10.1 pts−1.3 pts2.8 pts
From asset turnover–––––4.9 pts−2.7 pts−2.4 pts−0.2 pts−0.6 pts
From borrowing–––––1.1 pts0.6 pts0.1 pts−0.1 pts−0.2 pts
Return on capital employed––––9.3%17.9%16.3%6.3%5.0%5.5%
Cash conversion––––77.0%36.5%200.3%69.2%268.6%322.4%
Interest cover1.15.14.11.518.010.47.92.51.92.3
Debt to equity––––0.160.370.400.470.330.32
Receivable days––––12371110127133129
Inventory days––––642839839285
Payable days––––157108127140155177
Cash conversion cycle, days––––30−922707037
Working capital days––––68188111411679
Asset turnover––––0.821.120.980.700.670.62
Assets per rupee of net worth––––1.561.651.711.731.671.63
Sales per rupee of plant––––2.302.221.881.711.932.00
Capital spending to depreciation––––3.815.715.170.930.281.18
Plant being built, % of plant in use––––10.0%1.8%–2.4%0.0%2.2%
Revenue growth and operating profit growth are left blank for the year to Mar 2018: between the two periods the company restated its earlier figures, so the two are on different bases and the change is not worked out. No balance sheet is on record for the years to Mar 2017, Mar 2018, Mar 2019 and Mar 2020, so its lines and the ratios worked from it are blank there.

Growth and returns over 3, 5 and 10 years

Standalone: the listed company alone, without its subsidiaries. Each window ends with the year to Mar 2026.

Return on assets, latest year
4.0%
Cash from operations against operating profit
169.5%
Measure10 years5 years3 years
Revenue growth, yearly rate–16.9%0.2%
Profit growth, yearly rate–10.0%−16.4%
Return on equity, average–11.0%5.7%
Return on capital employed, average–10.2%5.6%
Operating margin, average12.6%15.3%12.4%
Net margin, average5.4%7.4%5.2%
Asset turnover, average–0.820.66
Cash conversion cycle, days, average–3859
Interest cover, average5.55.02.2
Debt to equity, average–0.380.37

Where the cash came from and went

Standalone: the listed company alone, without its subsidiaries. ₹ crore, added up over each window, which ends with the year to Mar 2026.

₹ crore5 years3 yearsLatest year
Cash from operations1036036
Cash from investing−185−79−34
Cash from financing8219−3
Capital spending862010
Dividends paid210
Shares bought back000
Shares issued for cash59280
Borrowings raised55163
Borrowings repaid770

Accounting checks

Standalone, years to March. Published tests of whether reported profit is backed by cash and the balance sheet.

CheckMar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Effective tax ratePublished threshold 17.16 per cent−98.7333.95––––––––
A threshold marked as ours has no published figure; it is the line we read the check against.

Credit ratings

An agency's view of the chance the company repays a borrowing on time, from AAA, the highest, down to D, in default.

DateAgencyBorrowing ratedRatingOutlookAmount, ₹ Cr
19 Mar 2026Infomerics Valuation and Ratings Private LimitedLong Term FacilitiesIVR BB+New, NewStable56.35
19 Mar 2026Infomerics Valuation and Ratings Private LimitedShort Term FacilitiesIVR A4+New, New2.80
13 Aug 2025ICRA LimitedFund Based-Term Loan[ICRA]BB+Review, DowngradeStable30
13 Aug 2025ICRA LimitedFund Based-Cash Credit[ICRA]BB+Review, DowngradeStable27.50
13 Aug 2025ICRA LimitedNon Fund Based-Others[ICRA]A4+Review, Downgrade2.80
13 Aug 2025ICRA LimitedFund Based-Others[ICRA]A4+Review, Downgrade2.50
The latest rating on each borrowing. The agency's name opens its reasoning for the rating.